-
1
-
-
77955893501
-
Long-term survival of cancer patients compared to heart failure and stroke: a systematic review
-
Askoxylakis V., Thieke C., Pleger S.T., et al. Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer 2010, 10:105.
-
(2010)
BMC Cancer
, vol.10
, pp. 105
-
-
Askoxylakis, V.1
Thieke, C.2
Pleger, S.T.3
-
2
-
-
79952444246
-
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association
-
Heidenreich P.A., Trogdon J.G., Khavjou O.A., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123:933-944.
-
(2011)
Circulation
, vol.123
, pp. 933-944
-
-
Heidenreich, P.A.1
Trogdon, J.G.2
Khavjou, O.A.3
-
3
-
-
84855353573
-
Heart disease and stroke statistics-2012 update: a report from the American Heart Association
-
Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
-
(2012)
Circulation
, vol.125
-
-
Roger, V.L.1
Go, A.S.2
Lloyd-Jones, D.M.3
-
4
-
-
80054739874
-
National andregional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008
-
Chen J., Normand S.L., Wang Y., et al. National andregional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA 2011, 306:1669-1678.
-
(2011)
JAMA
, vol.306
, pp. 1669-1678
-
-
Chen, J.1
Normand, S.L.2
Wang, Y.3
-
5
-
-
33750731595
-
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
-
Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006, 296:2217-2226.
-
(2006)
JAMA
, vol.296
, pp. 2217-2226
-
-
Gheorghiade, M.1
Abraham, W.T.2
Albert, N.M.3
-
6
-
-
68949094510
-
Heart failure performance measures and outcomes: real or illusory gains
-
Fonarow G.C., Peterson E.D. Heart failure performance measures and outcomes: real or illusory gains. JAMA 2009, 302:792-794.
-
(2009)
JAMA
, vol.302
, pp. 792-794
-
-
Fonarow, G.C.1
Peterson, E.D.2
-
7
-
-
84855179168
-
The relationship between hospital admission rates and rehospitalizations
-
Epstein A.M., Jha A.K., Orav E.J. The relationship between hospital admission rates and rehospitalizations. NEngl J Med 2011, 365:2287-2295.
-
(2011)
NEngl J Med
, vol.365
, pp. 2287-2295
-
-
Epstein, A.M.1
Jha, A.K.2
Orav, E.J.3
-
8
-
-
34447539951
-
Repeated hospitalizations predict mortality in the community population with heart failure
-
Setoguchi S., Stevenson L.W., Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007, 154:260-266.
-
(2007)
Am Heart J
, vol.154
, pp. 260-266
-
-
Setoguchi, S.1
Stevenson, L.W.2
Schneeweiss, S.3
-
9
-
-
83455172647
-
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF
-
Wilcox J.E., Fonarow G.C., Yancy C.W., et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J 2012, 163:49-56.e2.
-
(2012)
Am Heart J
, vol.163
-
-
Wilcox, J.E.1
Fonarow, G.C.2
Yancy, C.W.3
-
10
-
-
79551582915
-
Hospital readmission as an accountability measure
-
Axon R.N., Williams M.V. Hospital readmission as an accountability measure. JAMA 2011, 305:504-505.
-
(2011)
JAMA
, vol.305
, pp. 504-505
-
-
Axon, R.N.1
Williams, M.V.2
-
11
-
-
84865258582
-
Resource utilization and costs following hospitalization of patients with chronic heart failure in the US
-
Korves C., Eldar-Lissai A., McHale J., et al. Resource utilization and costs following hospitalization of patients with chronic heart failure in the US. JMed Econ 2012, 15:925-937.
-
(2012)
JMed Econ
, vol.15
, pp. 925-937
-
-
Korves, C.1
Eldar-Lissai, A.2
McHale, J.3
-
12
-
-
84876337749
-
Strategies and opportunities for drug development in heart failure
-
Butler J., Fonarow G.C., Gheorghiade M. Strategies and opportunities for drug development in heart failure. JAMA 2013, 309:1593-1594.
-
(2013)
JAMA
, vol.309
, pp. 1593-1594
-
-
Butler, J.1
Fonarow, G.C.2
Gheorghiade, M.3
-
13
-
-
79851511096
-
Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase
-
Gheorghiade M., Pang P.S., O'Connor C.M., et al. Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase. Am Heart J 2011, 161:224-232.
-
(2011)
Am Heart J
, vol.161
, pp. 224-232
-
-
Gheorghiade, M.1
Pang, P.S.2
O'Connor, C.M.3
-
15
-
-
0034859710
-
Renal effects of adenosine A1-receptor antagonists in congestive heart failure
-
Gottlieb S.S. Renal effects of adenosine A1-receptor antagonists in congestive heart failure. Drugs 2001, 61:1387-1393.
-
(2001)
Drugs
, vol.61
, pp. 1387-1393
-
-
Gottlieb, S.S.1
-
16
-
-
0037133628
-
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy
-
Gottlieb S.S., Brater D.C., Thomas I., et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002, 105:1348-1353.
-
(2002)
Circulation
, vol.105
, pp. 1348-1353
-
-
Gottlieb, S.S.1
Brater, D.C.2
Thomas, I.3
-
17
-
-
0033955058
-
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure
-
Gottlieb S.S., Skettino S.L., Wolff A., et al. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. JAm Coll Cardiol 2000, 35:56-59.
-
(2000)
JAm Coll Cardiol
, vol.35
, pp. 56-59
-
-
Gottlieb, S.S.1
Skettino, S.L.2
Wolff, A.3
-
18
-
-
77957730950
-
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
-
Massie B.M., O'Connor C.M., Metra M., et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. NEngl J Med 2010, 363:1419-1428.
-
(2010)
NEngl J Med
, vol.363
, pp. 1419-1428
-
-
Massie, B.M.1
O'Connor, C.M.2
Metra, M.3
-
19
-
-
0036023204
-
The prognostic importance of different definitions of worsening renal function in congestive heart failure
-
Gottlieb S.S., Abraham W., Butler J., et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. JCard Fail 2002, 8:136-141.
-
(2002)
JCard Fail
, vol.8
, pp. 136-141
-
-
Gottlieb, S.S.1
Abraham, W.2
Butler, J.3
-
20
-
-
77957984258
-
Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II
-
Goldenberg I., Gillespie J., Moss A.J., et al. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2010, 122:1265-1271.
-
(2010)
Circulation
, vol.122
, pp. 1265-1271
-
-
Goldenberg, I.1
Gillespie, J.2
Moss, A.J.3
-
21
-
-
77950485827
-
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study
-
Mebazaa A., Pang P.S., Tavares M., et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 2010, 31:832-841.
-
(2010)
Eur Heart J
, vol.31
, pp. 832-841
-
-
Mebazaa, A.1
Pang, P.S.2
Tavares, M.3
-
22
-
-
0037329098
-
Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure
-
Teerlink J.R. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Am Heart J 2003, 145:S26-S33.
-
(2003)
Am Heart J
, vol.145
-
-
Teerlink, J.R.1
-
23
-
-
77955436904
-
Areview of dyspnea in acute heart failure syndromes
-
West R.L., Hernandez A.F., O'Connor C.M., et al. Areview of dyspnea in acute heart failure syndromes. Am Heart J 2010, 160:209-214.
-
(2010)
Am Heart J
, vol.160
, pp. 209-214
-
-
West, R.L.1
Hernandez, A.F.2
O'Connor, C.M.3
-
24
-
-
41149148032
-
Aproposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
-
Pang P.S., Cleland J.G., Teerlink J.R., et al. Aproposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008, 29:816-824.
-
(2008)
Eur Heart J
, vol.29
, pp. 816-824
-
-
Pang, P.S.1
Cleland, J.G.2
Teerlink, J.R.3
-
25
-
-
77958606969
-
International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes
-
Collins S.P., Pang P.S., Lindsell C.J., et al. International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes. Eur J Heart Fail 2010, 12:1253-1260.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 1253-1260
-
-
Collins, S.P.1
Pang, P.S.2
Lindsell, C.J.3
-
26
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial
-
Konstam M.A., Gheorghiade M., Burnett J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297:1319-1331.
-
(2007)
JAMA
, vol.297
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett, J.C.3
-
27
-
-
33947719178
-
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials
-
Gheorghiade M., Konstam M.A., Burnett J.C., et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 2007, 297:1332-1343.
-
(2007)
JAMA
, vol.297
, pp. 1332-1343
-
-
Gheorghiade, M.1
Konstam, M.A.2
Burnett, J.C.3
-
28
-
-
67049117504
-
PhaseIII clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group
-
Gheorghiade M., Adams K.F., Cleland J.G., et al. PhaseIII clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J 2009, 157:957-970.
-
(2009)
Am Heart J
, vol.157
, pp. 957-970
-
-
Gheorghiade, M.1
Adams, K.F.2
Cleland, J.G.3
-
29
-
-
33644878033
-
Acute heart failure syndromes: current state and framework for future research
-
Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005, 112:3958-3968.
-
(2005)
Circulation
, vol.112
, pp. 3958-3968
-
-
Gheorghiade, M.1
Zannad, F.2
Sopko, G.3
-
30
-
-
0037181511
-
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial
-
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
-
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002, 287:1531-1540.
-
(2002)
JAMA
, vol.287
, pp. 1531-1540
-
-
-
31
-
-
0037181515
-
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial
-
Cuffe M.S., Califf R.M., Adams K.F., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541-1547.
-
(2002)
JAMA
, vol.287
, pp. 1541-1547
-
-
Cuffe, M.S.1
Califf, R.M.2
Adams, K.F.3
-
32
-
-
35848944656
-
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
-
McMurray J.J., Teerlink J.R., Cotter G., et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 2007, 298:2009-2019.
-
(2007)
JAMA
, vol.298
, pp. 2009-2019
-
-
McMurray, J.J.1
Teerlink, J.R.2
Cotter, G.3
-
33
-
-
34247857479
-
Levosimendan vs. dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial
-
Mebazaa A., Nieminen M.S., Packer M., et al. Levosimendan vs. dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007, 297:1883-1891.
-
(2007)
JAMA
, vol.297
, pp. 1883-1891
-
-
Mebazaa, A.1
Nieminen, M.S.2
Packer, M.3
-
34
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
O'Connor C.M., Starling R.C., Hernandez A.F., et al. Effect of nesiritide in patients with acute decompensated heart failure. NEngl J Med 2011, 365:32-43.
-
(2011)
NEngl J Med
, vol.365
, pp. 32-43
-
-
O'Connor, C.M.1
Starling, R.C.2
Hernandez, A.F.3
-
35
-
-
84864687000
-
Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial
-
Collins S.P., Lindsell C.J., Pang P.S., et al. Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial. Am Heart J 2012, 164:138-145.
-
(2012)
Am Heart J
, vol.164
, pp. 138-145
-
-
Collins, S.P.1
Lindsell, C.J.2
Pang, P.S.3
-
36
-
-
55049127403
-
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program
-
Blair J.E., Zannad F., Konstam M.A., et al. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. JAm Coll Cardiol 2008, 52:1640-1648.
-
(2008)
JAm Coll Cardiol
, vol.52
, pp. 1640-1648
-
-
Blair, J.E.1
Zannad, F.2
Konstam, M.A.3
-
37
-
-
84855708993
-
Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific)
-
Atherton J.J., Hayward C.S., Wan Ahmad W.A., et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). JCard Fail 2012, 18:82-88.
-
(2012)
JCard Fail
, vol.18
, pp. 82-88
-
-
Atherton, J.J.1
Hayward, C.S.2
Wan Ahmad, W.A.3
-
38
-
-
84894556346
-
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions
-
[Epub ahead of print]
-
Gheorghiade M., Vaduganathan M., Greene S.J., et al. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Fail Rev 2012, [Epub ahead of print].
-
(2012)
Heart Fail Rev
-
-
Gheorghiade, M.1
Vaduganathan, M.2
Greene, S.J.3
-
39
-
-
84873095762
-
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Trial
-
Butler J., Subacius H., Vaduganathan M., et al. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Trial. JAm Coll Cardiol 2013, 61(5):571-579.
-
(2013)
JAm Coll Cardiol
, vol.61
, Issue.5
, pp. 571-579
-
-
Butler, J.1
Subacius, H.2
Vaduganathan, M.3
-
40
-
-
77953635924
-
Prediction modeling using EHR data: challenges, strategies, and a comparison of machine learning approaches
-
21
-
Wu J., Roy J., Stewart W.F. Prediction modeling using EHR data: challenges, strategies, and a comparison of machine learning approaches. Med Care 2010, 48:S106-S113. 21.
-
(2010)
Med Care
, vol.48
-
-
Wu, J.1
Roy, J.2
Stewart, W.F.3
-
41
-
-
84879723243
-
-
Drug makers join efforts in research. The New York Times, September 19, 2012. Available at: Accessed December 13
-
Pollack A. Drug makers join efforts in research. The New York Times, September 19, 2012. Available at: Accessed December 13, 2012. http://www.nytimes.com/2012/09/20/health/drug-makers-in-joint-effort-to-streamlineresearch.
-
(2012)
-
-
Pollack, A.1
|